Reuters logo
a year ago
BRIEF-Shire's liver disease drug gets fast track designation from U.S. FDA
July 29, 2016 / 11:11 AM / a year ago

BRIEF-Shire's liver disease drug gets fast track designation from U.S. FDA

July 29 (Reuters) - Shire Plc :

* Shire's SHP626 (volixibat) receives FDA fast track designation for an investigational treatment for adults who have nonalcoholic steatohepatitis (nash) with liver fibrosis Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below